Risk of Severe Hematologic Toxicities in Cancer Patients Treated With PARP Inhibitors: A Meta-Analysis of Randomized Controlled Trials
Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s147726
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2017
Authors
Publisher
Informa UK Limited